Vancomycin-resistant Staphylococcus aureus

Jump to: navigation, search

For patient information click here

Vancomycin-resistant Staphylococcus aureus Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Vancomycin-resistant Staphylococcus aureus On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Vancomycin-resistant Staphylococcus aureus

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Vancomycin-resistant Staphylococcus aureus

CDC on Vancomycin-resistant Staphylococcus aureus

Vancomycin-resistant Staphylococcus aureus in the news

Blogs on Vancomycin-resistant Staphylococcus aureus

Directions to Hospitals Treating Vancomycin-resistant Staphylococcus aureus

Risk calculators and risk factors for Vancomycin-resistant Staphylococcus aureus

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and Keywords: VRSA; VISA; vancomycin-intermediate Staphylococcus aureus

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1

Related Chapters

External Links

http://www.cdc.gov/ncidod/dhqp/ar_visavrsa.html


Linked-in.jpg